Qi Deng
Clinical trials sponsored by Qi Deng, explained in plain language.
-
One-Shot cancer treatment? new CAR-T therapy skips lab, aims to slash cost
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy designed to be simpler and potentially cheaper. It aims to treat adults and teens with B-cell leukemia or lymphoma that has returned or not responded to standard treatments. Instead of modifying a patient's cells …
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New 'Living Drug' trial targets Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study is testing the safety and effectiveness of a new type of CAR-T cell therapy called GPRC5D CAR-T. It is for adults and teens (14-75) with advanced plasma cell cancers, like multiple myeloma, that have come back or stopped responding to other treatments, incl…
Phase: EARLY_PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC